{"organizations": [], "uuid": "1bfcb2a62135e79464ca24c4b65a83b63995fd2b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180125.html", "section_title": "Archive News &amp; Video for Thursday, 25 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-synergy-pharmaceuticals-announces/brief-synergy-pharmaceuticals-announces-fda-approval-of-trulance-idUSASB0C29T", "country": "US", "domain_rank": 408, "title": "BRIEF-Synergy Pharmaceuticals Announces FDA Approval Of TRULANCE", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-01-25T19:10:00.000+02:00", "replies_count": 0, "uuid": "1bfcb2a62135e79464ca24c4b65a83b63995fd2b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-synergy-pharmaceuticals-announces/brief-synergy-pharmaceuticals-announces-fda-approval-of-trulance-idUSASB0C29T", "ord_in_thread": 0, "title": "BRIEF-Synergy Pharmaceuticals Announces FDA Approval Of TRULANCE", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "synergy pharmaceuticals inc", "sentiment": "negative"}, {"name": "brief-synergy pharmaceuticals announces fda", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) - Synergy Pharmaceuticals Inc:\n* SYNERGY PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF TRULANCE® (PLECANATIDE) FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) IN ADULTS\n* SYNERGY PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF TRULANCE® (PLECANATIDE) FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) IN ADULTS Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-25T19:10:00.000+02:00", "crawled": "2018-01-26T21:13:49.000+02:00", "highlightTitle": ""}